PHARMACY

The FDA has given its blessing to Coherus BioSciences for Udenyca, which is a biosimilar of Amgen’s Neulasta.

Bristol-Myers’ Empliciti provides a new immunotherapy combination for patients with relapsed or refractory multiple myeloma.

The Whitehouse Station, N.J.-based chain will be transferring prescription records from nine of its stores to CVS Pharmacy, with plans for CVS Pharmacy to purchase and operate one location in the future.

National Diabetes Awareness Month offers a timely opportunity for pharmacists and their staff to review the important role they play in supporting the more than 30 million people who are managing this chronic condition, as well as to create loyalty.

CVS Health president and CEO Larry Merlo highlighted some of the company's plans that will be initiated once its acquisition of health insurer Aetna is completed.

Elite Pharmaceuticals and Glenmark, the company's marketing alliance partner, are set to launch generic methadone tablets in two dosage strengths.

Lannett is launching generic versions of Biaxin and Comtan, which market values of about $8 million and $24 million respectively, through an expanded agreement with Sunshine Lake.

Lupin has received the Food and Drug Administration's approval for generic Hectoral injection, which had a market value of about $133 million.